Skip to main content
. 2009 Jul 27;2:31. doi: 10.1186/1756-8722-2-31

Table 4.

Drug-Related Adverse Events Reported by ≥ 15% of Patients Who Received Vorinostat Combination Therapy in the Vorinostat Clinical Trial Program (Data Cut-Off April 2008)

Adverse Event No. (%) of Patients (N = 157)

All Grades Grade 3 or 4
Nausea 76 (48.4) 8 (5.1)
Diarrhea 64 (40.8) 9 (5.7)
Fatigue 54 (34.4) 21 (13.4)
Vomiting 49 (31.2) 6 (3.8)
Anorexia 32 (20.4) 4 (2.5)
Dehydration 28 (17.8) 6 (3.8)
Thrombocytopenia 25 (15.9) 15 (9.6)
Anemia 25 (15.9) 4 (2.5)